Interestingly, in all CML cases, the average normalized ratio for SMAD5 and TGF-βR2 was significantly lower than in healthy individuals (P < 0.001) (Figure 2B(Fig. 2)). This evidence concerns the gene TGFBR2 and chronic myelogenous leukemia, BCR-ABL1 positive.